| PRODUCT AT-A-GLANCE | PRODUCT AT-A-GLANCE | |||
|---|---|---|---|---|
| Product: | Phospholine Iodide® |  |
||
| Description: | 0.125% echothiophate iodide for ophthalmic solution | |||
| NDC #: | 48102-053-05 | |||
| Type: | Rx | |||
| Size: | 5 mL | |||
| Unit of Sale: | Kit containing product, diluent and dropper | |||
|
||||
| WHOLESALER INFORMATION FOR HEALTHCARE PROVIDERS | ||
|---|---|---|
| For customer service or ordering information, call 414-434-6604 or fax 414-434-4603. |
||
Phospholine Iodide® (echothiophate iodide for ophthalmic solution) is indicated for the reduction of elevated intraocular pressure (IOP) as well as for the treatment of accommodative esotropia.
The elevated IOP of glaucoma can affect both children and adults. In fact, Phospholine Iodide may be of particular clinical utility in treating aphakic glaucoma, which can occur as a complication of cataract surgery in both young children and adults. By controlling elevated eye pressure in such patients, these important eye drops may also help preserve vital vision.
As a treatment for accommodative esotropia (the inward turning of the eye) which can cause focusing problems, Phospholine Iodide has proven to be an invaluable therapeutic option to help correct or stabilize the condition, potentially obviating the need for more heroic measures. Or when a young child refuses or has difficulty wearing their corrective glasses, there is still a treatment option that can help.
For years, Phospholine Iodide has been manufactured and marketed by Pfizer. However, for a variety of reasons, Pfizer decided to discontinue the production of this important medication in May 2021.
We are also pleased to make available co-pay assistance for patients who qualify. Patients would pay no more than $100 for their prescription. The program is administered by the pharmacy so there are no cards or coupons to worry about.
For more information about patient assistance or ordering, contact AllianceRx Walgreens Pharmacy at 888-347-3416.
It would be great to
have it available
yesterday
It has some
niches that are
pretty unique
This isn’t a rare
disease medicine—
it is just not the most
common disease
medication
Phospholine Iodide is used for reduction of elevated intraocular pressure and for accommodative esotropia in children.
Do not use Phospholine Iodide if you have active uveal inflammation or if you are allergic to any ingredient in Phospholine Iodide. Do not use Phospholine Iodide with most cases of angle-closure glaucoma.
Wash hands before and after eye drop instillation. Put pressure on the inside corner of the eye with your finger for 1 to 2 minutes following instillation
Use caution and tell your doctor before using Phospholine Iodide if you have: asthma, stomach ulcer, gastrointestinal spasms, slow heartbeat, low blood pressure, recent heart attack, seizures, Parkinson’s disease, or a history of retinal detachment.
Temporarily discontinue the medication and tell your doctor right away if irregular heartbeat, breathing problem, muscle weakness, increased diarrhea, urination, salivation, and/or sweating occurs.
Certain medications, such as succinylcholine and other anticholinesterase medications, may cause more side effects and should only be used with great caution.
Certain types of pesticides, such as organophosphate and carbamate pesticides, may cause more side effects. Wearing a respiratory mask, and frequent washing and clothing change may be recommended around them.
Phospholine Iodide may cause eye irritation, including redness, stinging, burning, tearing, eyelid twitching, and blurred eye sight.
Iris cysts may form more frequently in children. The cysts usually shrink upon discontinuation of the medication or reducing the frequency of instillation. Talk with your doctor.
For additional information, please click here for Prescribing Information.
You are encouraged to report side effects to the FDA at http://www.FDA.gov/medwatch or 1-800-FDA-1088.
Phospholine Iodide is used for reduction of elevated intraocular pressure and for accommodative esotropia in children.
Do not use Phospholine Iodide if you have active uveal inflammation or if you are allergic to any ingredient in Phospholine Iodide. Do not use Phospholine Iodide with most cases of angle-closure glaucoma.
Wash hands before and after eye drop instillation. Put pressure on the inside corner of the eye with your finger for 1 to 2 minutes following instillation.
Use caution and tell your doctor before using Phospholine Iodide if you have: asthma, stomach ulcer, gastrointestinal spasms, slow heartbeat, low blood pressure, recent heart attack, seizures, Parkinson’s disease, or a history of retinal detachment.
Temporarily discontinue the medication and tell your doctor right away if irregular heartbeat, breathing problem, muscle weakness, increased diarrhea, urination, salivation, and/or sweating occurs.
Certain medications, such as succinylcholine and other anticholinesterase medications, may cause more side effects and should only be used with great caution.
Certain types of pesticides, such as organophosphate and carbamate pesticides, may cause more side effects. Wearing a respiratory mask, and frequent washing and clothing change may be recommended around them.
Phospholine Iodide may cause eye irritation, including redness, stinging, burning, tearing, eyelid twitching, and blurred eye sight.
Iris cysts may form more frequently in children. The cysts usually shrink upon discontinuation of the medication or reducing the frequency of instillation. Talk with your doctor.
For additional information, please click here for Prescribing Information.
You are encouraged to report side effects to the FDA at http://www.FDA.gov/medwatch or
| PIPELINE | ||
|---|---|---|
| Antiviral | Ophthalmic | FDA Approved Orphan Drug; Launch Pending |
| Corticosteroid | Ophthalmic | FDA Approved; Launch Pending |
| Alpha-adrenergic blocking agent | Ophthalmic | FDA Approved; Launch Pending |
| Anti-infective | Ophthalmic | FDA Approved; Launch Pending |
| Anti-infective | Ophthalmic | FDA Approved; Launch Pending |
| Mast Cell Stabilizer | Inhalation | FDA Approved; Launch Pending |
| F-100 | Ophthalmic | Early Development |
| F-102 | Ophthalmic | Orphan drug; Early Development |
| Cyclooxygenase-inhibiting nitric oxide donator | Oral | Orphan drug; Early Development |
Phospholine Iodide is used for reduction of elevated intraocular pressure and for accommodative esotropia in children.